Profile | GDS4284 / 217649_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 267.316 | 55 |
GSM687648 | Patient 402 control | 233.599 | 52 |
GSM687653 | Patient 403 control | 139.833 | 42 |
GSM687658 | Patient 404 control | 69.8317 | 27 |
GSM687663 | Patient 411 control | 285.504 | 54 |
GSM687668 | Patient 422 control | 147.934 | 43 |
GSM687673 | Patient 424 control | 204.958 | 48 |
GSM687678 | Patient 425 control | 303.269 | 55 |
GSM687683 | Patient 427 control | 171.794 | 43 |
GSM687688 | Patient 428 control | 461.602 | 63 |
GSM687695 | Patient 441 control | 64.9004 | 19 |
GSM687699 | Patient 443 control | 346.334 | 56 |
GSM687704 | Patient 444 control | 211.247 | 49 |
GSM687707 | Patient 448 control | 272.003 | 52 |
GSM687712 | Patient 449 control | 40.1575 | 20 |
GSM687719 | Patient 450 control | 129.326 | 35 |
GSM687724 | Patient 451 control | 273.004 | 53 |
GSM687728 | Patient 452 control | 655.054 | 68 |
GSM687646 | Patient 401 treated 24h | 419.654 | 60 |
GSM687649 | Patient 402 treated 24h | 316.462 | 57 |
GSM687665 | Patient 411 treated 24h | 203.838 | 47 |
GSM687651 | Patient 402 treated 4 weeks | 244.904 | 51 |
GSM687667 | Patient 411 treated 4 weeks | 134.653 | 40 |
GSM687670 | Patient 422 treated 24h | 250.846 | 51 |
GSM687671 | Patient 422 treated 4 weeks | 182.456 | 47 |
GSM687654 | Patient 403 treated 24h | 137.982 | 43 |
GSM687675 | Patient 424 treated 24h | 190.875 | 45 |
GSM687685 | Patient 427 treated 24h | 153.646 | 43 |
GSM687656 | Patient 403 treated 4 weeks | 112.334 | 39 |
GSM687677 | Patient 424 treated 4 weeks | 185.536 | 47 |
GSM687687 | Patient 427 treated 4 weeks | 179.144 | 48 |
GSM687692 | Patient 428 treated 4h | 218.902 | 50 |
GSM687716 | Patient 449 treated 4h | 141.306 | 42 |
GSM687722 | Patient 450 treated 4h | 174.861 | 42 |
GSM687680 | Patient 425 treated 24h | 258.693 | 53 |
GSM687690 | Patient 428 treated 24h | 446.645 | 63 |
GSM687700 | Patient 443 treated 24h | 331.523 | 52 |
GSM687705 | Patient 444 treated 24h | 160.241 | 46 |
GSM687714 | Patient 449 treated 24h | 71.165 | 30 |
GSM687721 | Patient 450 treated 24h | 99.1678 | 30 |
GSM687682 | Patient 425 treated 4 weeks | 268.206 | 55 |
GSM687694 | Patient 428 treated 4 weeks | 269.862 | 55 |
GSM687702 | Patient 443 treated 4 weeks | 237.174 | 49 |
GSM687718 | Patient 449 treated 4 weeks | 122.43 | 38 |
GSM687723 | Patient 450 treated 4 weeks | 183.431 | 45 |
GSM687661 | Patient 404 treated 4h | 118.891 | 37 |
GSM687710 | Patient 448 treated 4h | 246.033 | 53 |
GSM687726 | Patient 451 treated 4h | 255.269 | 51 |
GSM687730 | Patient 452 treated 4h | 269.351 | 39 |
GSM687660 | Patient 404 treated 24h | 184.948 | 42 |
GSM687697 | Patient 441 treated 24h | 358.337 | 55 |
GSM687709 | Patient 448 treated 24h | 214.332 | 48 |
GSM687725 | Patient 451 treated 24h | 192.359 | 44 |
GSM687729 | Patient 452 treated 24h | 519.695 | 64 |
GSM687727 | Patient 451 treated 4 weeks | 493.197 | 63 |
GSM687731 | Patient 452 treated 4 weeks | 332.492 | 56 |